-

Results of Comprehensive PBM Customer Satisfaction Research Released by Pharmaceutical Strategies Group

PSG’s Pharmacy Benefit Manager (PBM) Customer Satisfaction report explores more than 40 dimensions of PBM customer satisfaction from the viewpoint of employers and health plans

DALLAS--(BUSINESS WIRE)--The most comprehensive customer satisfaction report in the PBM space launches today. It delivers detailed intelligence to enhance the ability of payers and plan sponsors to manage pharmacy benefits strategically.

The 2020 PBM Customer Satisfaction Report is developed by Pharmaceutical Strategies Group (PSG), an EPIC company. This annual report summarizes overall satisfaction with PBMs and augments understanding of best practices.

“Selecting a PBM is a high-pressure decision,” said Sharon Phares, PhD, MPH, Senior Vice President of Research and Data Innovation at PSG. “Plan sponsors are locked into three-year contracts, and the cost of choosing incorrectly can be high. It can cost the sponsor and member money, frustration, and maybe even impact health outcomes.”

“Effective management of the significant investment in pharmacy benefits requires an in-depth understanding of the PBM landscape,” said Michael Lonergan, RPh, President of PSG. “Satisfaction is a crucial factor in PBM decisions, and that’s why I’m proud of the research we’re releasing today. Sharon and her team are providing valuable information that will inform crucial decision-making, strategic planning, and proactive management of member experience.”

Key takeaways from the 2020 PBM Customer Satisfaction Report include:

  • 90 percent of respondents feel their PBM financial relationship is somewhat/completely transparent
  • Likelihood to renew their PBM contract averaged 8.0 on a 10-point scale
  • Highest-rated core PBM function is retail network options
  • Highest-rated noncore PBM function is the account team acts as a strategic advisor
  • Highest-rated specialty management function is customer service for patients using specialty medications
  • Highest-rated PBM service dimension tied between meets financial guarantees and PBM staffing adequate to meet customer needs

Download the 2020 PBM Customer Satisfaction Report: https://www.psgconsults.com/pbmsatisfaction

About the 2020 PBM Customer Satisfaction Report

This annual report summarizes overall satisfaction with pharmacy benefit managers (PBM) and satisfaction with over 40 PBM functions and services beyond overall satisfaction. It is the most comprehensive research of its type for the PBM space. This report is widely recognized for the comparative information it provides to benefit executives responsible for researching, selecting, and managing PBMs.

About PSG

Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost management challenges. PSG’s innovative drug management solutions, including the proprietary data and analytics platform, Artemetrx, deliver actionable insights with exceptional financial and clinical value. PSG functions as a strategic partner through industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for clients every year.

Contacts

Samantha Rideout
Marketing Director, PSG
srideout@psgconsults.com
469.974.6152

Pharmaceutical Strategies Group


Release Summary
Results of the most comprehensive customer satisfaction research in the PBM space released today by Pharmaceutical Strategies Group.
Release Versions

Contacts

Samantha Rideout
Marketing Director, PSG
srideout@psgconsults.com
469.974.6152

Social Media Profiles
More News From Pharmaceutical Strategies Group

PSG Announces Results of Highly Comprehensive Pharmacy Benefit Manager Survey

DALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (PSG), an EPIC company, has released its 25th annual 2022 Pharmacy Benefit Manager Customer Satisfaction Report. This extensive report represents the most comprehensive satisfaction research survey in the pharmacy benefit manager (PBM) space, providing unparalleled data and insights. PBM satisfaction rankings in 2022 There was a notable downturn in overall satisfaction levels, as well as in some core measures of general satisfaction such...

PSG Announces New Features Designed to Support Biosimilar Strategy

DALLAS & SAN FRANCISCO--(BUSINESS WIRE)--Pharmaceutical Strategies Group (PSG), an EPIC company, announced an enhancement of its data and analytics platform, Artemetrx®, which will significantly enhance clients’ ability to track and report on the adoption of biosimilar medications. Artemetrx is the leading integrated pharmacy and medical claims platform and is utilized by health plans, pharmacy benefit managers, and employers for drug cost management. While biosimilars have been available in th...

Proprietary State of Specialty Spend and Trend Report Released by Pharmaceutical Strategies Group

DALLAS--(BUSINESS WIRE)--The Artemetrx Specialty Spend and Trend Report, by PSG, shows biosimilar adoption, but double-digit specialty drug trend persists....
Back to Newsroom